Vaicekauskaitė, I.;                     Kazlauskaitė, P.;                     Gineikaitė, R.;                     Čiurlienė, R.;                     Lazutka, J.R.;                     Sabaliauskaitė, R.    
        Integrative Analysis of Gene Expression and Promoter Methylation to Differentiate High-Grade Serous Ovarian Cancer from Benign Tumors. Biomedicines 2025, 13, 441.
    https://doi.org/10.3390/biomedicines13020441
    AMA Style
    
                                Vaicekauskaitė I,                                 Kazlauskaitė P,                                 Gineikaitė R,                                 Čiurlienė R,                                 Lazutka JR,                                 Sabaliauskaitė R.        
                Integrative Analysis of Gene Expression and Promoter Methylation to Differentiate High-Grade Serous Ovarian Cancer from Benign Tumors. Biomedicines. 2025; 13(2):441.
        https://doi.org/10.3390/biomedicines13020441
    
    Chicago/Turabian Style
    
                                Vaicekauskaitė, Ieva,                                 Paulina Kazlauskaitė,                                 Rugilė Gineikaitė,                                 Rūta Čiurlienė,                                 Juozas Rimantas Lazutka,                                 and Rasa Sabaliauskaitė.        
                2025. "Integrative Analysis of Gene Expression and Promoter Methylation to Differentiate High-Grade Serous Ovarian Cancer from Benign Tumors" Biomedicines 13, no. 2: 441.
        https://doi.org/10.3390/biomedicines13020441
    
    APA Style
    
                                Vaicekauskaitė, I.,                                 Kazlauskaitė, P.,                                 Gineikaitė, R.,                                 Čiurlienė, R.,                                 Lazutka, J. R.,                                 & Sabaliauskaitė, R.        
        
        (2025). Integrative Analysis of Gene Expression and Promoter Methylation to Differentiate High-Grade Serous Ovarian Cancer from Benign Tumors. Biomedicines, 13(2), 441.
        https://doi.org/10.3390/biomedicines13020441